Cargando…

The Association between LRRK2 G2385R and Phenotype of Parkinson's Disease in Asian Population: A Meta-Analysis of Comparative Studies

Numerous studies have investigated the relationship between the LRRK2 G2385R variant and clinical characteristics in Parkinson's disease (PD), but the results have been inconsistent. This study investigated whether the LRRK2 G2385R variant was associated with a unique clinical phenotype of PD i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di, Wei, Zeng, Zhiyong, Li, Jingyan, Liu, Xiaoling, Bo, Minzhi, Lv, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079378/ https://www.ncbi.nlm.nih.gov/pubmed/30123490 http://dx.doi.org/10.1155/2018/3418306

Ejemplares similares

Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants
por: Yang, Jing, et al.
Publicado: (2021)

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
por: Tezuka, Toshiki, et al.
Publicado: (2022)

Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease
por: Cui, Shi-Shuang, et al.
Publicado: (2021)

G2385R and I2020T Mutations Increase LRRK2 GTPase Activity
por: Ho, Dong Hwan, et al.
Publicado: (2016)

LRRK2 G2385R and R1628P Mutations Are Associated with an Increased Risk of Parkinson's Disease in the Malaysian Population
por: Gopalai, Aroma Agape, et al.
Publicado: (2014)

Curcumin Reduced H(2)O(2)- and G2385R-LRRK2-Induced Neurodegeneration
por: Zhang, Jinru, et al.
Publicado: (2021)

Connectivity of corticostriatal circuits in nonmanifesting LRRK2 G2385R and R1628P carriers
por: Zhang, Dongling, et al.
Publicado: (2022)

Effect of LRRK2 G2385R Variant on Subthalamic Deep Brain Stimulation Efficacy in Parkinson's Disease in a Han Chinese Population
por: Chen, Si, et al.
Publicado: (2019)

The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions
por: Carrion, Maria Dolores Perez, et al.
Publicado: (2017)

Genetic Analysis of LRRK2 R1628P in Parkinson's Disease in Asian Populations
por: Zhang, Yuan, et al.
Publicado: (2017)

A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene
por: Vinagre-Aragón, Ana, et al.
Publicado: (2021)

Relationship between LRRK2 R1628P polymorphism and Parkinson's disease in Asian populations
por: Zhao, Hui, et al.
Publicado: (2016)

Transgenic LRRK2(R1441G) rats–a model for Parkinson disease?
por: Shaikh, Komal T., et al.
Publicado: (2015)

Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor
por: Bright, Jessica M., et al.
Publicado: (2021)

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
por: Gaig, Carles, et al.
Publicado: (2014)

Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
por: San Luciano, Marta, et al.
Publicado: (2017)

2385 Role of the antioxidant enzyme catalase in respiratory syncytial virus infection
por: Ansar, Maria, et al.
Publicado: (2018)

Biological Stoichiometry Regulates Toxin Production in Microcystis aeruginosa (UTEX 2385)
por: Wagner, Nicole D., et al.
Publicado: (2019)

2385. Evaluating the Antibiotic Risk for Clostridioides difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime
por: Rathod, Shardul, et al.
Publicado: (2019)

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
por: Rui, Qin, et al.
Publicado: (2018)

A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson’s Disease Affects LRRK2 Protein Levels
por: Ogata, Jun, et al.
Publicado: (2021)

Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity
por: Shu, Yang, et al.
Publicado: (2016)

G2019S Variation in LRRK2: An Ideal Model for the Study of Parkinson’s Disease?
por: Ren, Chao, et al.
Publicado: (2019)

LRRK2 Mutations and Asian Disease-Associated Variants in the First Parkinson's Disease Cohort from Kazakhstan
por: Kaiyrzhanov, Rauan, et al.
Publicado: (2020)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

LRRK2 and Proteostasis in Parkinson’s Disease
por: Pérez-Carrión, María Dolores, et al.
Publicado: (2022)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Effect of Zinc on Microcystis aeruginosa UTEX LB 2385 and Its Toxin Production
por: Perez, Jose L., et al.
Publicado: (2020)

Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease
por: Thaler, Avner, et al.
Publicado: (2020)

miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease
por: Oliveira, Sara R., et al.
Publicado: (2021)

Spread of neuronal degeneration in a dopaminergic, Lrrk-G2019S model of Parkinson disease
por: Hindle, Samantha J., et al.
Publicado: (2013)

Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients
por: Duque, Andrés Felipe, et al.
Publicado: (2015)

LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease
por: Bouhouche, Ahmed, et al.
Publicado: (2017)

Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression
por: Ortega, Roberto A., et al.
Publicado: (2021)

Genetic Variants of LRRK2 in Taiwanese Parkinson’s Disease
por: Wu, Yih-Ru, et al.
Publicado: (2013)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

LRRK2 and the Endolysosomal System in Parkinson’s Disease
por: Erb, Madalynn L., et al.
Publicado: (2020)

LRRK2 at the Crossroad of Aging and Parkinson’s Disease
por: Hur, Eun-Mi, et al.
Publicado: (2021)

Pathological Functions of LRRK2 in Parkinson’s Disease
por: Jeong, Ga Ram, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4326lk20plgreasp7ve1356n12